Back to search

Article

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

2021-04-19

Abstract excerpt

As vaccines against SARS-CoV-2 are now being rolled out, a better understanding of immunity to the virus; whether through infection, or passive or active immunisation, and the durability of this protection is required. This will benefit from the ability to measure SARS-CoV-2 immunity, ideally with rapid turnaround and without the need for laboratory-based testing. Current rapid point-of-care (POC) tests measure an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fe24e7af-0d32-5b89-b9da-e894c6a4bfee
DOI
10.1101/2021.04.12.21255368
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2DOI 10.1101/2021.04.12.21255368
A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levelsSemantic proximity
Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variantsSemantic proximity
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity
Evaluation of a Rapid Semiquantitative Lateral Flow Assay for the Prediction of Serum Neutralizing Activity Against SARS-CoV-2 VariantsSemantic proximity
Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2Semantic proximity
Evaluation of SARS-CoV-2 Antibody Point of Care Devices in the Laboratory and Clinical SettingSemantic proximity
Performance of Lateral Flow Assays for SARS-CoV-2 Compared to RT-qPCRSemantic proximity
IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody ScreeningSemantic proximity
COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testingSemantic proximity
Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimensSemantic proximity
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity
Select a neighboring publication to make it the new centre.